standard-of-care imaging (PSMA/FDG PET/CT), ACP3 PET/CT
2025XJSLL-10
Unknown other active
Quick answer
standard-of-care imaging (PSMA/FDG PET/CT), ACP3 PET/CT for Prostate Cancer (Diagnosis) is a Unknown program (other) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Prostate Cancer (Diagnosis)
- Phase
- Unknown
- Modality
- other
- Status
- active